on Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Protagonist Therapeutics Engages in Key Investment Conferences
Protagonist Therapeutics, a biopharmaceutical company based in Newark, California, will participate in several investment bank conferences in September 2025. Dinesh V. Patel, Ph.D., President and CEO, will represent the company in these events.
The company will engage in a fireside chat at Citi's 2025 Biopharma Back to School Summit in Boston on September 3 and at the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 9. Protagonist will also participate in a panel about immunology at the BofA 11th Annual World Medical Innovation Forum in Boston on September 16.
Protagonist is advancing two peptides in Phase 3 clinical trials. Icotrokinra, in collaboration with J&J, and Rusfertide, developed with Takeda, are key focuses. Webcasts of these presentations will be accessible on the company's website for a year.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Protagonist Therapeutics, Inc. news